From: Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer
 | No. | Cumulative survival (%) | Median ± SE | 95% CI | p. value |
---|---|---|---|---|---|
Nm23 (-)& p53 (+) | 9 | 11 | 6 ± 1.49 | 3.08 – 8.92 |  |
Other combinations | 50 | 57 | 43 ± - | - | 0.0004 |
Nm23 (-)& EGFR (+) | 18 | 28 | 10 ± 3.18 | 3.76 – 16.24 |  |
Other combinations | 41 | 60 | 43 ± - | - | 0.029 |
EGFR (+)& p53 (+) | 11 | 18 | 6 ± 3.85 | 0 – 13.55 |  |
Other combinations | 48 | 58 | 43 ± - | - | 0.0002 |
Nm23 (-), p53 (+), EGFR (+) | 6 | 15 | 5.8 ± 3.85 | 0.1–13.55 | 0.0001 |
Other combinations | 53 | 59 | 43 ± - | - |  |
Nm23 (-), p53 (+), EGFR (+)& b (-) | 7 | 9 | 4 ± 5.62 | 1.45 – 20.21 | <0.0001 |
Other combinations | 52 | 58 | 50 ± - | - |  |